US FDA adding hearing loss risk impotence drugs

U.S. regulators on Thursday said warnings about the risk of sudden hearing loss linked to popular drugs for impotence, including Viagra, Cialis and Levitra, would be added to the drugs’ labels.

The U.S. Food and Drug Administration was prompted to look into a possible connection after a published report of a man taking Viagra, made by Pfizer Inc, who suffered from sudden hearing loss, a rare condition.

Eli Lilly sells Cialis and GlaxoSmithKline Plc sells Levitra.

A further review of the FDA’s side effect data found 29 cases of sudden hearing loss with a relationship to the three drugs. In two thirds of the cases, the hearing loss was ongoing, the agency said.

Print Version
Tell-a-Friend comments powered by Disqus

RELATED ARTICLES:

Addressing the needs of young women with disorders of sex development   HPV vaccination not associated with increase in sexually transmitted infections   FDA denies approval to wider use of J&J’s blood clot preventer   FDA Warns of Potential Risk of Severe Liver Injury With Use of Dronedarone   Low national funding for LGBT health research contributes to inequities, analysis finds   Sexual function dramatically improves in women following bariatric surgery, Penn study finds   Studying the health of same-sex couples   More sex for married couples with traditional divisions of housework   NTU study looks at national attitudes towards homosexuals   It’s Not Just About Showing Your Genitals: Time to Talk About Sexting   New York approves tougher legislation on circumcision   Infertility gene may lead to pill for men